• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 99-113 of 455 results

1026 Exhibit: FDA Guidance October 1999

Document IPR2016-01596, No. 1026-32 Exhibit - FDA Guidance October 1999 (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1023 Exhibit: PM360 April 1, 2012 Overactive Bladder Market

Document IPR2016-01596, No. 1023-29 Exhibit - PM360 April 1, 2012 Overactive Bladder Market (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1043 Exhibit: Comparison of Toviaz Sales to Compound to Pharmaceutical Ind Ben...

Document IPR2016-01596, No. 1043-49 Exhibit - Comparison of Toviaz Sales to Compound to Pharmaceutical Ind Benchmarks (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1033 Exhibit: Declaration of DeForest McDuff, PhD

Document IPR2016-01596, No. 1033-39 Exhibit - Declaration of DeForest McDuff, PhD (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1002 Exhibit: File History for USPN 6,858,650 Part 2

Document IPR2016-01596, No. 1002-3 Exhibit - File History for USPN 6,858,650 Part 2 (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1010 Exhibit: Postlind Drug Metabolism and Disposition 1998

Document IPR2016-01596, No. 1010-13 Exhibit - Postlind Drug Metabolism and Disposition 1998 (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1049 Exhibit: Consumer Price Index

Document IPR2016-01596, No. 1049-55 Exhibit - Consumer Price Index (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1035 Exhibit: Toviaz Dont Let Overactive Bladder Stop You In Your Tracks

Document IPR2016-01596, No. 1035-41 Exhibit - Toviaz Dont Let Overactive Bladder Stop You In Your Tracks (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1016 Exhibit: DeMaagd 2012

Document IPR2016-01596, No. 1016-22 Exhibit - DeMaagd 2012 (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1007 Exhibit: Brynne 1997

Document IPR2016-01596, No. 1007-10 Exhibit - Brynne 1997 (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1046 Exhibit: Present Value of Toviaz Worldwide Sales

Document IPR2016-01596, No. 1046-52 Exhibit - Present Value of Toviaz Worldwide Sales (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1040 Exhibit: Prescription Path of Toviaz and Other OABs

Document IPR2016-01596, No. 1040-46 Exhibit - Prescription Path of Toviaz and Other OABs (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1024 Exhibit: Toviaz Label Pfizer Labs

Document IPR2016-01596, No. 1024-30 Exhibit - Toviaz Label Pfizer Labs (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1045 Exhibit: Present Value of Toviaz US Sales

Document IPR2016-01596, No. 1045-51 Exhibit - Present Value of Toviaz US Sales (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze

1025 Exhibit: FDA Approval Letter NDA20 771

Document IPR2016-01596, No. 1025-31 Exhibit - FDA Approval Letter NDA20 771 (P.T.A.B. Aug. 22, 2016)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 7 8 9 10 11 ... >>